Percutaneous closure of patent foramen ovale: A wise approach;Indicazioni alla chiusura percutanea del forame ovale pervio: Una questione di buon senso

Giornale Italiano di Cardiologia

Volumn 9, Issue 9, 2008, Pages 593-602

  Gaspardone, Achille ^a   Iani, Cesare ^a   Papa, Marco ^b  

^a S EUGENIO HOSPITAL   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Migraine; Patent foramen ovale; Stroke; Transcatheter closure

Indexed keywords

ARTICLE; CEREBROVASCULAR DISEASE; DECOMPRESSION SICKNESS; DIVER; EMBOLISM; FETUS CIRCULATION; HUMAN; LUNG EDEMA; MIGRAINE; OBSERVATIONAL STUDY; PATENT FORAMEN OVALE; PATHOGENESIS; PREVALENCE; STROKE; SYMPTOM; TRANSIENT ISCHEMIC ATTACK;

CARDIAC SURGICAL PROCEDURES; FORAMEN OVALE, PATENT; HUMANS;

EID: 51049124525     PISSN: 18276806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Thompson T, Evans W. Paradoxical embolism. Quart J Med 1930; 23: 135-50.
2. Hagen PT, Sholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984; 59: 17-20.
3. Penther P. Patent foramen ovale: an anatomical study. Apropos of 500 consecutive autopsies. Arch Mal Coeur Vaiss 1994; 87: 15-21.
4. Messe SR, Silverman IE, Kizer JR, et al, for the Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004; 62: 1042-50.
5. Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989; 25: 382-90.
6. Cohnheim J. Trombose und embolie. Vorlesungen Uber Allegemenie Pathologie. Berlin: Hirschwald, 1877: 134.
7. Lethen H, Flachskampf FA, Schneider R, et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol 1997; 80: 1066-9.
8. Sommer RJ, Hijazi ZM, Rhodes JF Jr. Pathophysiology of congenital heart disease in the adult. Part I: Shunt lesions. Circulation 2008; 117: 1090-9.
9. Lechat P, Mass JL, Lescault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318: 1148-52.
10. Webster MW, Chancellor AM, Smith HJ, et al. Patent foramen ovale in young stroke patients. Lancet 1988; 2: 11-2.
11. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000; 55: 1172-9. La prima metanalisi che ha suggerito un rapporto tra forame ovale pervio e ictus criptogenetico nei soggetti con età <55 anni.
12. Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation 2005; 112: 1063-72. Una rassegna estremamente accurata che analizza i più importanti lavori relativamente alla prevenzione delle ricorrenze ischemiche nei pazienti trattati per via percutanea e con terapia medica ottimale.
13. Chen WJ, Lin SL, Cheng JJ, Lien WP. The frequency of patent foramen ovale in patients with ischemic stroke: a transesophageal echocardiographic study. J Formos Med Assoc 1991; 90: 744-8.
14. de Belder MA, Tourikis L, Leech G, Camm AJ. Risk of patent foramen ovale for thromboembolic events in all age groups. Am J Cardiol 1992; 69: 1316-20.
15. Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992; 117: 461-5.
16. Hausmann D, Mugge A, Becht I, Daniel WG. Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol 1992; 70: 668-72.
17. Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993; 24: 1865-73.
18. Job FP, Ringeistein EB, GrafenY, et al. Comparison of transcranial contrast Doppler sonography and transesophageal contrast echocardiography for the detection of patent foramen ovale in young stroke patients. Am J Cardiol 1994; 74: 381-4.
19. Jones EE Calafiore P, Donnan GA, Tonkin AM. Evidence that patent foramen ovale is not a risk factor for cerebral ischemia in the elderly. Am J Cardiol 1994; 74: 596-9.
20. Zahn R, Lehmkuhl S, Lotter R, Zander M, Senges J. Cardiac sources of cerebral ischemic events with special regard to a patent foramen ovale. Herz Kerislauf 1995; 74: 279-84.
21. Del Sette M, Angeli S, Leandri M, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 1998; 8: 327-30.
22. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP, for the PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: Patent Foramen Ovale in Cryptogenic Stroke Study. Circulation 2002; 105: 2625-31.
23. Mas JL, Arquizan C, Lamy C, et al, for the Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345: 1740-6.
24. Slottow TL, Steinberg DH, Waksman R. Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on patent foramen ovale closure devices. Circulation 2007; 116: 677-82. Una presa di posizione chiara della Food and Drug Administration sulle indicazioni alla chiusura percutanea transcatetere del forame ovale pervio.
25. Landzberg MJ, Khairy P. Indications for the closure of patent foramen ovale. Heart 2004; 90: 219-24.
26. Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 1991; 37: 11-23.
27. D'Alessandro R, Benassi G, Lenzi PL, et al. Epidemiology of headache in the Republic of San Marino. J Neurol Neurosurg Psychiatry 1988; 51: 21-7.
28. Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci 1993; 20: 131-7.
29. Henry P, Michel P, Brochet P, Dartigues JF, Tison S, Salamon R. A nationwide survey of migraine in France: prevalence and clinical features in adults. Cephalalgia 1992; 12: 229-37.
30. Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Results of the Zurich cohort study of young adults. Arch Gen Psychiatry 1990; 47: 849-53.
31. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol 1991; 44: 1147-57.
32. Lavados PM, Tenhamm E. Epidemiology of migraine headache in Santiago, Chile: a prevalence study. Cephalalgia 1997; 17: 770-7.
33. Montiel I, Muniz R, Asensio M, et al. Prevalence of migraine in a homogeneous population using the self-questionnaire "Alcoi-1995". Rev Neurol 1997; 25: 1177-80.
34. Sakai F, Igarashi H. Prevalence of migraine in Japan: a nationwide survey. Cephalalgia 1997; 17: 15-22.
35. Muniz R, Macia C, Montiel I, et al. Prevalence of migraine in the medical student population as determined by means of the "Acoi 1992" questionnaire. Rev Neurol 1995; 23: 870-3.
36. Lipton RB, Liberman JN, Kolodner KB, Bigal ME, Dowson A, Stewart WF. Migraine headache disability and health-related quality-of-life: a population-based case-control study from England. Cephalalgia 2003; 23: 441-50.
37. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001; 41: 646-57.
38. Silberstein SD. Migraine. Lancet 2004; 363: 381-91.
39. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000; 356: 1648-51.
40. Domitrz I, Mieszkowski J, Kwiecinski H. The prevalence of patent foramen ovale in patients with migraine. Neurol Neurochir Pol 2004; 38: 89-92.
41. Schwerzmann M, Nedeltchev K, Lagger F, et al. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 2005; 65: 1415-8.
42. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999; 52: 1622-5.
43. Milhaud D, Bogousslavsky J, van Melle G, Liot P. Ischemic stroke and active migraine. Neurology 2001; 57: 1805-11.
44. Lamy C, Giannesini C, Zuber M, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA study. Atrial Septal Aneurysm. Stroke 2002; 33: 706-11.
45. Carod-Artal FJ, da Silveira Ribeiro L, Braga H, Kummer W, Mesquita HM, Vargas AP. Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients. A transcranial Doppler study. Cephalalgia 2006; 26: 934-9.
46. Sztajzel R, Genoud D, Roth S, Mermillod B, Le Floch-Rohr J. Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002; 13: 102-6.
47. Wilmshurst PT, Nightingale S. The role of cardiac and pulmonary pathology in migraine: a hypothesis. Headache 2006; 46: 429-34.
48. Morandi E, Anzola GP, Angeli S, Melzi G, Onorato E. Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol 2003; 16: 39-42.
49. Wilmshurst PT, Pearson MJ, Nightingale S, Walsh KP, Morrison WL. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart 2004; 90: 1315-20.
50. Wilmshurst P, Bryson P. Relationship between the clinical features of neurological decompression illness and its causes. Clin Sci (Lond) 2000; 99: 65-75.
51. Post MC, Thijs V, Herroelen L, Budts WI. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004; 62: 1439-40.
52. Schwerzmann M, Wiher S, Nedeltchev K, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004; 62: 1399-401.
53. Azarbal B, Tobis J, Suh W, Chan V, Dao C, Gaster R. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol 2005; 45: 489-92.
54. Reisman M, Christofferson RD, Jesurum J, et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005; 45: 493-5.
55. Giardini A, Donti A, Formigari R, et al. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am Heart J 2006; 151: 922. e1 -5.
56. Anzola GP, Frisoni GB, Morandi E, Casilli F Onorato E. Shunt-associated migraine responds favorably to atrial septal repair: a case-control study. Stroke 2006; 37: 430-4. Questo studio riporta l'esperienza di un singolo centro relativamente all' effetto favorevole della chiusura transcatetere del forame ovale pervio in soggetti con emicrania. È uno studio elegante e ben disegnato i cui risultati sono molto convincenti.
57. Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008; 117: 1397-404. Il MIST è l'unico studio controllato, randomizzato, multicentrico e prospettico pubblicato finora. Benché i risultati siano fondamentalmente negativi, questo studio è fortemente influenzato da importanti limitazioni metodologiche.
58. Carroll JD. Migraine Intervention With STARFlex Technology trial: a controversial trial of migraine and patent foramen ovale closure. Circulation 2008; 117: 1358-60.
59. Reul J, Weis J, Jung A, Willmes K, Thron A. Central nervous system lesions and cervical disc herniations in amateur divers. Lancet 1995; 345: 1403-5.
60. Knauth M, Ries S, Pohimann S, et al. Cohort study of multiple brain lesions in sport divers: role of a patent foramen ovale. BMJ 1997; 314: 701-5.
61. Schwerzmann M, Seiler C, Lipp E, et al. Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers. Ann Intern Med 2001; 134: 21-4.
62. Torti SR, Billinger M, Schwerzmann M, et al. Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale. Eur Heart J 2004; 25: 1014-20.
63. Landzberg MJ, Sloss LJ, Faherty CE, et al. Orthodeoxiaplatypnea due to intracardiac, shunting - relief with transcatheter double umbrella closure. Cathet Cardiovasc Diagn 1995; 36: 247-50.